In their discussion of ER− GWAS results, Milne et al. suggest that stimulation of the beta 2 adrenergic-adenylate cyclase-cAMP-β-arrestin–Src–ERK pathway may play a role in the genesis of ER− breast cancer. The gene discussed is SRC; the disease is breast carcinoma.